Risk factors predictive of chronic postsurgical neuropathic pain: The value of the iliac crest bone harvest model

Acute neuropathic characteristics and secondary hyperalgesia are independent, additive factors predictive of chronic postsurgical pain after iliac crest bone harvest. Nerve lesions and secondary hyperalgesia may both be present after surgery, and their relative contributions to chronic postsurgical...

Full description

Saved in:
Bibliographic Details
Published inPain (Amsterdam) Vol. 153; no. 7; pp. 1478 - 1483
Main Authors Martinez, Valeria, Ben Ammar, Skander, Judet, Thierry, Bouhassira, Didier, Chauvin, Marcel, Fletcher, Dominique
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Elsevier B.V 01.07.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acute neuropathic characteristics and secondary hyperalgesia are independent, additive factors predictive of chronic postsurgical pain after iliac crest bone harvest. Nerve lesions and secondary hyperalgesia may both be present after surgery, and their relative contributions to chronic postsurgical neuropathic pain (CPSNP) remain unclear. This prospective study explored the roles of these factors in the development of CPSNP after iliac crest bone harvest. CPSNP was defined as pain in the area of hypoesthesia, with a positive Douleur neuropathique 4 questionnaire (DN4) score 3months after iliac crest bone harvest. The location, intensity, and neuropathic characteristics of pain were evaluated in 82 patients who were followed for 6months. Neuropathic characteristics were assessed by clinical examination and DN4 questionnaire. The area of secondary hyperalgesia was evaluated 48h and 1month after surgery. The area of mechanical hypoesthesia, detection, and mechanical pain threshold were evaluated at 48h and at 1 and 3months. Nineteen patients (23%) had CPSNP at 3months. The patients who developed CPSNP had a larger area of secondary hyperalgesia at 48h (88cm2 vs 33cm2; P=.001), higher pain intensity (numerical rating scale 6.7 vs 4.7; P=.02), and higher neuropathic characteristics score on the DN4 questionnaire (4.3 vs 2.3; P=.001). However, neither the area nor the severity of hypoesthesia differed significantly between patients with and without CPSNP. Two independent, additive predictors of CPSNP were identified: area of secondary hyperalgesia (odds ratio 1.02; P=.004) and DN4 score (odds ratio 1.94; P=.001). These findings suggest that both nerve lesions and central sensitization are involved in CPSNP development and could be seen as early warning signs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-3959
1872-6623
DOI:10.1016/j.pain.2012.04.004